Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-10-018461)

Filing Details

Accession Number:: 0001209191-10-018461
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-03-23 13:00:00
Reporting Period:: 2010-03-22

Filing Date:: 2010-03-23
Accepted Time:: 2010-03-23 21:30:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087432	Intermune Inc	ITMN	Pharmaceutical Preparations (2834)	943296648

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1206199	G Daniel Welch	3280 Bayshore Boulevard Brisbane CA 94005	Ceo And President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-03-22	35,000	$40.34	171,897	No	4	S	Direct
Common Stock	Acquisiton	2010-03-22	9,891	$10.11	181,788	No	4	M	Direct
Common Stock	Acquisiton	2010-03-22	7,849	$12.74	189,637	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Incentive Stock Option (Right to Buy)	Disposition	2010-03-22	9,891	$0.00	9,891	$10.11
Common Stock	Incentive Stock Option (Right to Buy)	Disposition	2010-03-22	7,849	$0.00	7,849	$12.74

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2008-09-10	2014-09-10	No	4	M	Direct
0	2009-06-24	2015-06-24	No	4	M	Direct

Footnotes

The shares sold by the reporting person were previously purchased in the open market, and a portion of the proceeds from their sale was used to purchase the underlying shares from an option exercise.